Literature DB >> 31477805

Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases.

Abbas Abi1, Najmeh Farahani2, Ghader Molavi3,4, Seyed Mohammad Gheibi Hayat5.   

Abstract

The most frequent kind of malignancy in the universe is skin cancer, which has been categorized into non-melanoma and melanoma skin cancer. There are no complete information of the skin carcinogenesis process. A variety of external and internal agents contribute to the non-melanoma and melanoma skin cancer pathogenesis. These factors are epigenetic changes, X-rays, genetic, arsenic compounds, UV rays, and additional chemical products. It was found that there could be a relationship between the appearing novel and more suitable therapies for participants in this class of diseases and detection of basic molecular paths. A covalently closed loop structure bond connecting the 5' and 3' ends characterizes a new group of extensively expressed endogenous regulatory RNAs, which are called circular RNAs (circRNAs). Mammals commonly express circRNAs. They are of high importance in tumorigenesis. Multiple lines evidence indicated that a variety of circular RNAs are associated with initiation and development of skin-related diseases such as skin cancers. Given that different circular RNAs (hsa_circ_0025039, hsa_circRNA006612, circRNA005537, and circANRIL) via targeting various cellular and molecular targets (e.g., CDK4, DAB2IP, ZEB1, miR-889, and let-7c-3p) exert their effects on skin cancers progression. Herein, for first time, we summarized different circular RNAs in skin cancers and noncancerous diseases. Moreover, we highlighted crosstalk between circular RNAs and ceRNAs in cancerous conditions.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31477805     DOI: 10.1038/s41417-019-0130-x

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  95 in total

Review 1.  Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.

Authors:  Eshini Perera; Neiraja Gnaneswaran; Carolyn Staines; Aung Ko Win; Rod Sinclair
Journal:  Australas J Dermatol       Date:  2015-02-25       Impact factor: 2.875

2.  A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation.

Authors:  Vanessa M Conn; Véronique Hugouvieux; Aditya Nayak; Stephanie A Conos; Giovanna Capovilla; Gökhan Cildir; Agnès Jourdain; Vinay Tergaonkar; Markus Schmid; Chloe Zubieta; Simon J Conn
Journal:  Nat Plants       Date:  2017-04-18       Impact factor: 15.793

3.  Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994.

Authors:  Eva Månsson-Brahme; Hemming Johansson; Olle Larsson; Lars E Rutqvist; Ulrik Ringborg
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

4.  The burden of malignant melanoma--lessons to be learned from Austria.

Authors:  Babak Monshi; Marin Vujic; Danijel Kivaranovic; Alma Sesti; Willi Oberaigner; Igor Vujic; Susana Ortiz-Urda; Christian Posch; Hans Feichtinger; Monika Hackl; Klemens Rappersberger
Journal:  Eur J Cancer       Date:  2016-01-20       Impact factor: 9.162

5.  Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases.

Authors:  Andreas Stang; Eero Pukkala; Risto Sankila; Bengt Söderman; Timo Hakulinen
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

6.  Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer.

Authors:  Huijun Xie; Xiaoli Ren; Sainan Xin; Xiaoliang Lan; Guifeng Lu; Yuan Lin; Shaoshan Yang; Zhicheng Zeng; Wenting Liao; Yan-Qing Ding; Li Liang
Journal:  Oncotarget       Date:  2016-05-03

7.  circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family.

Authors:  L Chen; S Zhang; J Wu; J Cui; L Zhong; L Zeng; S Ge
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

8.  Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Yong-Hua Xu; Qi Zheng; Zi Chen; Wei Song; Jian Zhou; Zhao-You Tang; Xin-Yu Huang
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

9.  Talimogene laherparepvec (T-VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report.

Authors:  J Ressler; R Silmbrod; A Stepan; F Tuchmann; A Cicha; K Uyanik-Ünal; C Hoeller
Journal:  Br J Dermatol       Date:  2019-03-26       Impact factor: 9.302

10.  CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Xi Jin; Chun-Yan Feng; Zun Xiang; Yi-Peng Chen; You-Ming Li
Journal:  Oncotarget       Date:  2016-10-11
View more
  4 in total

1.  Screening of cashmere fineness-related genes and their ceRNA network construction in cashmere goats.

Authors:  Taiyu Hui; Yuanyuan Zheng; Chang Yue; Yanru Wang; Zhixian Bai; Jiaming Sun; Weidong Cai; Xinjiang Zhang; Wenlin Bai; Zeying Wang
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

2.  Circular RNA expression profile in transgenic diabetic mouse kidneys.

Authors:  Xuan Xiong; Changchun Liu; Meiren Shen; Qian Yang; Qiang Zhao; Xiaoyan Li; Xiaoshi Zhong; Zhiwei Wang
Journal:  Cell Mol Biol Lett       Date:  2021-06-07       Impact factor: 5.787

3.  CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p.

Authors:  Tianfang Xia; Zhenguo Pan; Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

Review 4.  The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma.

Authors:  Barbara Montico; Giorgio Giurato; Giovanni Pecoraro; Annamaria Salvati; Alessia Covre; Francesca Colizzi; Agostino Steffan; Alessandro Weisz; Michele Maio; Luca Sigalotti; Elisabetta Fratta
Journal:  Mol Oncol       Date:  2021-06-18       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.